HUMAN MORICIZINE METABOLISM .1. ISOLATION AND IDENTIFICATION OF METABOLITES IN HUMAN URINE

Citation
Le. Richards et al., HUMAN MORICIZINE METABOLISM .1. ISOLATION AND IDENTIFICATION OF METABOLITES IN HUMAN URINE, Xenobiotica, 27(2), 1997, pp. 217-229
Citations number
24
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
Journal title
ISSN journal
00498254
Volume
27
Issue
2
Year of publication
1997
Pages
217 - 229
Database
ISI
SICI code
0049-8254(1997)27:2<217:HMM.IA>2.0.ZU;2-D
Abstract
1. Using synthetic standards and/or spectral data, seven moricizine me tabolites were structurally identified in human urine. Two novel metab olites were identified as phenothiazine-2-carbamic acid and ethyl [10- (3-aminopropionyl) phenothiazin-2-yl] carbamate. Two novel human moric izine metabolites, 2-amino-10-(3-morpholinopropionyl) phenothiazine, a previously identified dog metabolite, and 2-aminophenothiazine, a pre viously identified rat metabolite, were also identified. Three additio nal human metabolites, phenothiazine-2-carbamic acid ethyl ester sulph oxide (P2CAEES), moricizine sulphoxide, and ethyl {10-[N-(2'-hydroxyet hyl)3-aminopropionyl] phenothiazin-2-yl} carbamate, all previously des cribed in the literature, were observed. 2. Both 2-amino-10-(3-morphol inopropionyl) phenothiazine and ethyl [10-(3-aminopropionyl) phenothia zin-2-yl] carbamate, and possibly ethyl 2'-hydroxyethl)3-aminopropiony l]phenothiazin-2-yl} carbamate, possess the structural characteristics thought to be necessary for class 1 antiarrhythmic activity.